NCT03458416View on ClinicalTrials.gov

A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

September 6, 2018

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Prader-Willi Syndrome
Interventions
DRUG

Cannabidiol Oral Solution

An oral solution containing pharmaceutical grade cannabidiol (nonplant-based).

Trial Locations (1)

Washington

"Institute for Research and Innovation , MultiCare Health System"

Sponsors

Collaborators (1)

Benuvia Therapeutics Inc.
All Listed Sponsors
collaborator

Benuvia Therapeutics Inc.

INDUSTRY

lead

Radius Pharmaceuticals, Inc.

INDUSTRY